Our state-of-the-art laboratories are fully equipped for efficient preformulation and development of solutions, gels, creams and capsules. Nuvisan's highly experienced scientists develop varied formulation concepts that de-risk formulation development while ensuring efficiency, effectiveness and robustness. In parallel, our compositions provide appropriate delivery, stability, tolerance and sensory characteristics.
learn more
Nuvisan specialises in non-sterile dosage form development, including tailored topical, semi-solid and liquid formulations. We select excipients to meet molecule and indication needs to support the creation of effective, well-tolerated and elegant formulas that enable successful scale-up. Our robust formulation process, grounded in experience with marketed products, is designed to manage risks and maximise clinical study potential.
learn more
Nuvisan provides GMP-compliant manufacturing services for non-sterile dosage forms, including topical, semi-solid and liquid formulations. Our state-of-the-art facilities ensure the highest standards of quality and regulatory compliance, supporting the production of scalable, safe and effective products.
learn more
Nuvisan offers comprehensive in vitro testing services to support drug development, including permeation studies, in vitro release testing (IVRT), in vitro pharmacodynamic tests (e.g. inflammation platform) and in vitro toxicity tests. Using advanced techniques like in vitro skin permeability testing (IVPT) with human skin explants, we provide critical data on drug delivery to enable formulation optimisation. This data, combined with in vitro toxicity tests, supports safety assessments. Our in vitro testing facilitates the effective and targeted development of dermatological products.
learn more
Contact Us
Search